Intravitreal bevacizumab as an adjuvant treatment of choroidal metastasis

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0681-j.1755-3768.2016.0681

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal bevacizumab for the treatment of choroidal metastasis

By  

ACTA OPHTHALMOLOGICA, Vol. 92, Iss. 1, 2014-02 ,pp. : e80-e82

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 3, 2015-08 ,pp. : 431-434

John Wiley & Sons Inc

Access to resources Recommend Favorite

Esophageal Metastasis to the Iris Effectively Palliated Using Stereotactic Body Radiation Therapy and Adjuvant Intravitreal Chemotherapy: Case Report and Literature Review

By  

Case Reports in Oncology, Vol. 5, Iss. 3, 2012-12 ,pp. : 639-643

Karger

Access to resources Recommend Favorite

Complete Remission in a Colon Cancer Patient with a Large, Irresectable Liver Metastasis after XELOX/Cetuximab/Bevacizumab Treatment

By  

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-08 ,pp. : 464-467

Karger

Access to resources Recommend Favorite